Tokyo, Japan

Tatsuo Matsunaga


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Tatsuo Matsunaga

Introduction

Tatsuo Matsunaga is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for inner ear hearing impairment. His innovative work has led to the filing of two patents that showcase his expertise and dedication to improving health outcomes.

Latest Patents

Matsunaga's latest patents focus on novel apoptosis inhibitors and therapeutic agents aimed at treating inner ear hearing impairment. These patents include biguanide compounds and rapamycin derivatives as active ingredients. The structural formulas provided in his patents detail the specific chemical compositions and potential applications of these compounds, highlighting their importance in the pharmaceutical industry.

Career Highlights

Matsunaga is affiliated with Keio University, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to address significant health challenges related to hearing loss. His innovative approach and commitment to research have positioned him as a key figure in his area of expertise.

Collaborations

Matsunaga has worked alongside notable colleagues such as Makoto Hosoya and Masato Fujioka. Their collaborative efforts have contributed to advancing research in therapeutic agents and enhancing the understanding of inner ear conditions.

Conclusion

Tatsuo Matsunaga's contributions to the field of pharmaceuticals, particularly in developing treatments for inner ear hearing impairment, demonstrate his innovative spirit and commitment to improving health outcomes. His work continues to inspire future research and development in this critical area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…